-
Resilient Pharmaceutical Supply Chains in Times of Crisis: A Comparative Analysis of Australia, France, Italy, Spain, and UK
Sep 9, 2025, 16:22 PM -
Systematic Review of Prognostic Factors for Efficacy and Safety Outcomes in CAR-T Cell Therapy for Diffuse Large B-cell Lymphoma
Sep 9, 2025, 16:22 PM -
Managed Reimbursement of Continuous Glucose Monitoring Sensors in Ireland: Year One Review
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use and Mortality After Diabetic Ketoacidosis: Insights From Linked Primary- and Secondary-Care Data in the UK
Sep 9, 2025, 16:22 PM -
Evolving Trends in Patient Demographics and Diagnosis in Gastric Cancer: A Real-World Analysis From US Community Oncology Practices From 2014 to 2024
Sep 9, 2025, 16:22 PM -
Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries
Sep 9, 2025, 16:22 PM -
Development of Two Versions of a Patient-Reported Outcome Measure to Evaluate Participant Experience and Satisfaction During the Intervention and Analytical Treatment Interruption Periods of Cure-Related and Other HIV Trials
Sep 9, 2025, 16:22 PM -
Health Economic Evaluations of Prevention and Management Strategies for Cholangiocarcinoma: A Systematic Review
Sep 9, 2025, 16:22 PM -
The Role of Unpaid Work in Measuring the Social Costs of Disease
Sep 9, 2025, 16:22 PM -
Fezolinetant Veoza™ As a Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms in Postmenopausal Women: A Systematic Literature Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Weighting the OrPhar-SEFH MCDA Framework for Its Use in Ultrarare Kidney Diseases
Sep 9, 2025, 16:22 PM -
Assessing the Value of Purewick™ System for the Management of Female Patients With Urinary Incontinence in the Nonacute Setting: Preliminary Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Impact of Real-World Effectiveness vs. Previous Assumptions on Estimates of Economic and Clinical Benefit of 20-Valent Pneumococcal Conjugate Vaccine in Adults Across Countries
Sep 9, 2025, 16:22 PM -
Trends and Scope of Japan’s Across-the-Board Pharmaceutical Price Revisions in FY2021-25
Sep 9, 2025, 16:22 PM -
The Phantom Menace: How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access
Sep 9, 2025, 16:22 PM -
Real-World Cancer Treatments for Common Solid Tumors in China: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Generalizability of a Randomized Clinical Trial-Based Prediction Model in a Real-World Population
Sep 9, 2025, 16:22 PM -
Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib
Sep 9, 2025, 16:22 PM -
Timing Matters: Missed Opportunity to Prevent RSV Cases in Older Adults in Germany: A Markov Model Analysis
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM
